MedTrace Logo

Intravenous Tramadol and Magnesium Sulphate for Prevention of Shivering

NCT06612996 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2024-09-25

No results posted yet for this study

Summary

The aim of this work was to compare the efficacy of intravenous (IV) tramadol versus magnesium sulphate added to 100 ml saline for prevention of shivering associated with spinal anesthesia.

Conditions

  • Lower Extremity Chronic Venous Ulcers
  • Varicose Veins Leg
  • Hernia

Interventions

DRUG

Tramadol

Intravenous tramadol

DRUG

Magnesium sulphate

Intravenous magnesium sulphate

OTHER

Saline

Normal saline

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-10
Primary Completion
2025-01-10
Completion
2025-01-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06612996 on ClinicalTrials.gov